BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 23239665)

  • 1. The isolation and characterization of renal cancer initiating cells from human Wilms' tumour xenografts unveils new therapeutic targets.
    Pode-Shakked N; Shukrun R; Mark-Danieli M; Tsvetkov P; Bahar S; Pri-Chen S; Goldstein RS; Rom-Gross E; Mor Y; Fridman E; Meir K; Simon A; Magister M; Kaminski N; Goldmacher VS; Harari-Steinberg O; Dekel B
    EMBO Mol Med; 2013 Jan; 5(1):18-37. PubMed ID: 23239665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wilms' tumor blastemal stem cells dedifferentiate to propagate the tumor bulk.
    Shukrun R; Pode-Shakked N; Pleniceanu O; Omer D; Vax E; Peer E; Pri-Chen S; Jacob J; Hu Q; Harari-Steinberg O; Huff V; Dekel B
    Stem Cell Reports; 2014 Jul; 3(1):24-33. PubMed ID: 25068119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ALDH activity selectively defines an enhanced tumor-initiating cell population relative to CD133 expression in human pancreatic adenocarcinoma.
    Kim MP; Fleming JB; Wang H; Abbruzzese JL; Choi W; Kopetz S; McConkey DJ; Evans DB; Gallick GE
    PLoS One; 2011; 6(6):e20636. PubMed ID: 21695188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted therapy aimed at cancer stem cells: Wilms' tumor as an example.
    Shukrun R; Pode Shakked N; Dekel B
    Pediatr Nephrol; 2014 May; 29(5):815-23; quiz 821. PubMed ID: 23760992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developmental tumourigenesis: NCAM as a putative marker for the malignant renal stem/progenitor cell population.
    Pode-Shakked N; Metsuyanim S; Rom-Gross E; Mor Y; Fridman E; Goldstein I; Amariglio N; Rechavi G; Keshet G; Dekel B
    J Cell Mol Med; 2009 Aug; 13(8B):1792-1808. PubMed ID: 20187302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. STAT3 is necessary for proliferation and survival in colon cancer-initiating cells.
    Lin L; Liu A; Peng Z; Lin HJ; Li PK; Li C; Lin J
    Cancer Res; 2011 Dec; 71(23):7226-37. PubMed ID: 21900397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BMP-2 inhibits tumor-initiating ability in human renal cancer stem cells and induces bone formation.
    Wang L; Park P; La Marca F; Than KD; Lin CY
    J Cancer Res Clin Oncol; 2015 Jun; 141(6):1013-24. PubMed ID: 25431339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD133+, CD166+CD44+, and CD24+CD44+ phenotypes fail to reliably identify cell populations with cancer stem cell functional features in established human colorectal cancer cell lines.
    Muraro MG; Mele V; Däster S; Han J; Heberer M; Cesare Spagnoli G; Iezzi G
    Stem Cells Transl Med; 2012 Aug; 1(8):592-603. PubMed ID: 23197865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CITED1 confers stemness to Wilms tumor and enhances tumorigenic responses when enriched in the nucleus.
    Murphy AJ; Pierce J; de Caestecker C; Ayers GD; Zhao A; Krebs JR; Saito-Diaz VK; Lee E; Perantoni AO; de Caestecker MP; Lovvorn HN
    Oncotarget; 2014 Jan; 5(2):386-402. PubMed ID: 24481423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival.
    Silva IA; Bai S; McLean K; Yang K; Griffith K; Thomas D; Ginestier C; Johnston C; Kueck A; Reynolds RK; Wicha MS; Buckanovich RJ
    Cancer Res; 2011 Jun; 71(11):3991-4001. PubMed ID: 21498635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice.
    O'Brien CA; Pollett A; Gallinger S; Dick JE
    Nature; 2007 Jan; 445(7123):106-10. PubMed ID: 17122772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blastemal NCAM
    Raved D; Tokatly-Latzer I; Anafi L; Harari-Steinberg O; Barshack I; Dekel B; Pode-Shakked N
    Pathol Res Pract; 2019 Aug; 215(8):152491. PubMed ID: 31202518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of CD133 in the identification and characterisation of tumour-initiating cells in non-small-cell lung cancer.
    Tirino V; Camerlingo R; Franco R; Malanga D; La Rocca A; Viglietto G; Rocco G; Pirozzi G
    Eur J Cardiothorac Surg; 2009 Sep; 36(3):446-53. PubMed ID: 19464919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and propagation of a human CD133(-) colon tumor-derived cell line with tumorigenic and angiogenic properties.
    Navarro-Alvarez N; Kondo E; Kawamoto H; Hassan W; Yuasa T; Kubota Y; Seita M; Nakahara H; Hayashi T; Nishikawa Y; Hassan RA; Javed SM; Noguchi H; Matsumoto S; Nakaji S; Tanaka N; Kobayashi N; Soto-Gutierrez A
    Cell Transplant; 2010; 19(6):865-77. PubMed ID: 20587145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD133 expression defines a tumor initiating cell population in primary human ovarian cancer.
    Curley MD; Therrien VA; Cummings CL; Sergent PA; Koulouris CR; Friel AM; Roberts DJ; Seiden MV; Scadden DT; Rueda BR; Foster R
    Stem Cells; 2009 Dec; 27(12):2875-83. PubMed ID: 19816957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wilms tumor--a renal stem cell malignancy?
    Pode-Shakked N; Dekel B
    Pediatr Nephrol; 2011 Sep; 26(9):1535-43. PubMed ID: 21499773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation therapy: targeting human renal cancer stem cells with interleukin 15.
    Azzi S; Bruno S; Giron-Michel J; Clay D; Devocelle A; Croce M; Ferrini S; Chouaib S; Vazquez A; Charpentier B; Camussi G; Azzarone B; Eid P
    J Natl Cancer Inst; 2011 Dec; 103(24):1884-98. PubMed ID: 22043039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of CD56 in Normal Kidney Development and Wilms Tumorigenesis.
    Yap LW; Brok J; Pritchard-Jones K
    Fetal Pediatr Pathol; 2017 Feb; 36(1):62-75. PubMed ID: 27935326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subpopulation of small-cell lung cancer cells expressing CD133 and CD87 show resistance to chemotherapy.
    Kubo T; Takigawa N; Osawa M; Harada D; Ninomiya T; Ochi N; Ichihara E; Yamane H; Tanimoto M; Kiura K
    Cancer Sci; 2013 Jan; 104(1):78-84. PubMed ID: 23066953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD133 and CD44 cell surface markers do not identify cancer stem cells in primary human gastric tumors.
    Rocco A; Liguori E; Pirozzi G; Tirino V; Compare D; Franco R; Tatangelo F; Palaia R; D'Armiento FP; Pollastrone G; Affuso A; Bottazzi EC; Masone S; Persico G; Nardone G
    J Cell Physiol; 2012 Jun; 227(6):2686-93. PubMed ID: 21898409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.